Cleared Traditional

K170132 - MyoCycle Home, MyoCycle Pro

K170132 is an FDA 510(k) clearance for MyoCycle Home, manufactured by Myolyn, LLC. The device is a Class 2 Neurology device with product code GZI cleared through the Traditional 510(k) pathway after a 98-day FDA review.

K170132 · Myolyn, LLC · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2017
Decision
98d
Days
Class 2
Risk

K170132 is an FDA 510(k) clearance for the MyoCycle Home, MyoCycle Pro. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Myolyn, LLC (Gainesville, US). The FDA issued a Cleared decision on April 25, 2017 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5810 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K170132

510(k) Number K170132 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 17, 2017
Decision Date April 25, 2017
Days to Decision 98 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 149d · This submission: 98d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZI Device Classification - Class 2, Special Controls

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 55
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K170132.
Foot Drop System (Model XFT-2001D)
K162718 · Shenzhen Xft Medical Limited · Nov 2017
MyndMove System, MyndMove Functional Electrical Stimulator
K170564 · Myndtec, Inc. · Aug 2017
RT300 FES cycle ergometer
K162470 · Restorative Therapies, Inc. · Jul 2017
RehaStim 2
K162683 · Hasomed GmbH · Feb 2017
L300 Go System
K162407 · Bioness, Inc. · Jan 2017
ReGrasp
K153163 · Rehabtronics, Inc. · Apr 2016